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The arcuate nucleus of the hypothalamus is a key regulator of energy balance
and glucose homeostasis. In particular, arcuate proopiomelanocortin (POMC) neurons
inhibit food intake, stimulate energy expenditure and increase glucose tolerance.
The interruption of insulin or glucose signaling in POMC neurons leads to glucose
intolerance without changing energy homeostasis. Although it was previously shown
that POMC neurons are necessary for normal glucose homeostasis, the participation
of POMC neuropeptide, by mechanisms independent of energy balance, remains to be
demonstrated. To study the role of POMC in the regulation of glucose homeostasis, we
performed glucose and insulin tolerance tests in non-obese mice lacking hypothalamic
POMC expression. We found that POMC deficiency leads to glucose intolerance and
insulin resistance in female mice before the onset of obesity or hyperphagia. Conversely,
POMC deficiency does not impair glucose homeostasis in non-obese male mice.
Interestingly, females completely normalize both glucose and insulin tolerance after
genetic POMC restoration. Next, to further study sex dimorphism of POMC neurons
regarding glucose homeostasis, we measured glucose-elicited changes in C-FOS by
performing immunofluorescence in brain slices of POMC-EGFP mice. Remarkably, we
found that glucose-induced C-FOS expression in POMC neurons is more than 3-fold
higher in female than in male mice. Altogether, our results reveal a key role of arcuate
POMC in the regulation of glucose homeostasis in females. Since POMC reactivation
completely reverses the diabetogenic phenotype, arcuate POMC could be a potential
target for diabetes therapy.
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INTRODUCTION
Diabetes mellitus is a condition affecting 422 million people all over the world (1). Type 2 diabetes
is the predominant type, and it mainly results from excess body weight and physical inactivity
(1). In obese patients and mice, type 2 diabetes greatly improves or even reverts after mild body
weight loss (2–4). It is accepted that the improvement in glucose homeostasis is a consequence
of fat mass reduction, especially in the liver. However, since the hypothalamus is a key regulator
of both glucose and energy homeostasis, hypothalamic mechanisms may also be implicated in the
anti-diabetic consequences of losing weight (5, 6).
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Within the arcuate nucleus of the hypothalamus,
proopiomelanocortin (POMC) neurons sense the energy
status of the organism integrating peripheral signals such as
leptin, glucose and insulin, among others (7). In turn, POMC
neurons coordinate responses to maintain energy balance and
glucose homeostasis. Since melanocyte-stimulating hormones
(α- and β-MSH) derived from POMC peptide are anorexigenic,
POMC deficient patients and mice are extremely obese (8, 9).
Regarding the role of POMC neurons in glucose homeostasis,
some studies using electrophysiology on brain slices showed
that POMC neuron activity can be modulated by changes
in extracellular glucose levels (10–12). Moreover, deleting
components of the insulin, leptin or glucose signaling cascades in
POMC neurons impairs glucose tolerance and insulin sensitivity
in genetically engineered mice (10, 12, 13). In addition, glucose
induces both Pomc mRNA expression as well as α-MSH release
from hypothalamic neurons (12, 14). Although the role of
POMC neurons in glucose homeostasis has been well established,
it remains to be elucidated if hypothalamic POMC peptide
is directly involved, especially considering that these neurons
may also co-secrete glutamate, gamma-aminobutyric acid and
Cocaine and Amphetamine Regulated Transcript (15).
We have previously shown that hypothalamic POMC
deficiency leads both to obesity and type 2 diabetes (2).
Interestingly, restoration of POMC expression in extremely
obese POMC-deficient mice induces partial body weight loss but
complete normalization of glycemia (2). These results suggest
that the reestablishment of glucose homeostasis may not only be
a consequence of losing weight but also of Pomc restoration itself,
which would imply a direct protective role of POMC against
type 2 diabetes. In the present work, in order to test the role of
POMC in glucose homeostasis independently of its role in body
weight maintenance, we determine glucose tolerance and insulin
sensitivity in non-obese POMC-deficient mice.
MATERIALS AND METHODS
Animal Care
Mice were kept under standard laboratory conditions, with
controlled photoperiod (lights on from 7 a.m. to 7 p.m.), tap
water and standard lab chow available ad libitum. Mice were
weaned at P21. All procedures were approved by the Institutional
Animal Care and Use Committee of the School of Medicine,
University of Buenos Aires.
Mouse Lines
arcPomc−/− [Figure 1A; (2)], POMC-EGFP (16) and Cre:ERT
[B6.Cg-Tg(cre/Esr1)5Amc/J] (17) mice were kindly provided by
Marcelo Rubinstein, INGEBI-CONICET and bred as previously
described (2).
Glucose, Insulin and Pyruvate Tolerance
Tests (GTT, ITT and PTT)
Three cohorts of postnatal day 22–25 (P22-25) mice were
subjected to GTT, ITT, or PTT (Figure 1B). To avoid excessive
weight loss in weanling mice, GTTs and PTTs were performed
following 5-h fasting (8 a.m. to 1 p.m.), as suggested (18), and
received an i.p injection of glucose (2 g/kg; Sigma) or sodium
pyruvate (2 g/kg; Anedra). For ITTs mice were fasted for 2 h
(8 a.m. to 10 a.m.) and i.p injected with human insulin (Humulin
R; 1 U/kg; Lilly). Blood samples from the tail tip were taken
to measure glucose with a One Touch R© glucometer (LifeScan,
Johnson & Johnson), before and after injections, as described
previously (19). Immediately after GTT or ITT, mice were treated
with tamoxifen and re-tested at P60.
CRE Induction by Tamoxifen
Administration
Mice were injected i.p. with 50 mg/kg/day tamoxifen
(Sigma) during five consecutive days, with a solution of 5mg
tamoxifen/ml of semsame oil (Sigma) prepared as described (20).
Food Intake and Fat Determination
Another cohort of individually housed arcPomc−/−:Cre and Cre
mice was used for food intake assessment from P21 to P25. After
that, mice were euthanized by cervical dislocation and unilateral
subcutaneous (inguinal) and visceral (retroperitoneal) fat pads,
as well as livers, were dissected and weighed.
Immunohistochemistry
Mice were anesthetized with 5% chloral hydrate, perfused
with 4% paraformaldehyde and brains were cut into 35µm
coronal sections with a frozen microtome (Leica). Hypothalamic
POMC reactivation was confirmed by immunohistochemistry
(Figure 1C) using a rabbit polyclonal anti rat-ACTH antibody
(1:1,000, A.F. Parlow, National Hormone and Peptide
Program, Harbor-UCLA Medical Center) and developed
with diaminobenzidine (Vector Labs) as previously described
(2). For C-FOS detection, P22-P25 POMC-EGFP mice were
fasted from 8 a.m. to 1 p.m., and then i.p injected either
with glucose (2 g/kg) or saline. 90-120min later brains were
processed as stated above, immunostained for C-FOS (rabbit
anti C-FOS, Merck, 1:1,000) and developed with anti-rabbit-
Cy3 antisera (Jackson ImmunoResearch, 1:500). Double
immunohistochemistry: (1) mouse monoclonal IgG2a anti
C-FOS (Santa Cruz Biotechnologies, 1:4,000) followed by
anti-mouse IgG2a-Alexa Fluor 555 antisera (ThermoFisher,
1:1,000); (2) rabbit anti ER alpha antibody (Millipore, 1:10,000)
followed by biotinylated anti-rabbit antisera (Vector Labs,
1:200) and developed by streptavidin-Alexa Fluor 647 (Jackson
ImmunoResearch, 1:15,000). No staining was performed to
visualize POMC neurons since POMC-EGFP mice express
EGFP in this neuronal population. Micrographs were taken
with an AxioImager M2 motorized fluorescent microscope with
Apotome2 structured illumination (Zeiss). Positive neurons
were counted using Image J software (21).
Statistical Analysis
All data are presented as the mean ± SEM and were analyzed
by Student’s unpaired two-tailed t-test, one or two way ANOVA
(OWA, TWA) or repeated measures ANOVA (RMA), using
GraphPad Prism version 6.00 for Windows (GraphPAd Software,
La Jolla California, United States). Post hoc Bonferroni’s test
was used when necessary. P < 0.05 was considered significant.
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FIGURE 1 | Pomc regulation of glucose homeostasis in a mouse model of reversible hypothalamic Pomc deficiency. (A) A reversible arcuate Pomc deficient mouse
line (arcPomc−/−) was intercrossed with Cre-ERT line to restore Pomc expression. arcPomc−/−contains an insertion of a neomycin resistance cassette (neo), flanked
by loxP sites (triangles), interrupting Pomc neuronal enhancer activity (Blue circle: nPE1 enhancer; gap after neo: Deleted nPE2 enhancer). Gray circle: intact Pomc
pituitary promoter. arc: arcuate Pomc transcription. Black rectangles: Pomc exons. Pomc expression can be restored by treating arcPomc−/−:Cre mice with
(Continued)
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FIGURE 1 | tamoxifen (TAM). (B) General experimental design. Mice are weaned at P21 and subjected either to Glucose, Insulin or Pyruvate Tolerance Tests (GTT, ITT,
or PTT) at P22-P25 (PRE). Mice are treated with TAM for five consecutive days immediately after the first GTT or ITT. At P60, GTT or ITT was repeated (POST). (C)
Examples of brain coronal sections subjected to immunohistochemistry for POMC in non-treated mice (PRE) and mice treated with TAM (POST). Note that
arcPomc−/−:Cre mice only show POMC immune-positive neurons after POMC restoration by TAM treatment. Sections correspond to P60-P80 mice. (D-E) GTTs
and body weights (insets) of females before (PRE) or after (POST) POMC restoration. p: genotype effect of RMA. **p < 0.01 (Bonferroni). n = 7–8. (F) Area under the
curves (AUC) of (D,E). p: genotype effect of RMA. *p < 0.05; **p < 0.01 (Bonferroni). (G,H) ITTs and body weights of females before (PRE) or after (POST) POMC
restoration. p: genotype effect of RMA. *p < 0.05 (Bonferroni). n = 11. (I) Daily food intake of female mice measured from P21 to P25. T-test, p > 0.05. n = 8–11.
(J–L) Weights of retroperitoneal and inguinal fat pads, and livers of female mice at P25. T-test, p > 0.05. n = 6. (M) PTTs and body weights of females before POMC
restoration. RMA: genotype and genotype x time effects, p > 0.05. n = 5–6. (N,O) GTT and ITT of weanling male mice, respectively. RMA, genotype and genotype x
time effect: p > 0.05. Insets: body weights. n = 6–8 (GTT) and n = 7 (ITT). (P) Daily food intake of male mice from P21 to P25. n = 10–12. T-test, p > 0.05. (Q–S)
Weights of retroperitoneal and inguinal fat pads, and livers of male mice at P25. T-test, p>0.05. n = 5–6. (T) PTTs and body weights of males before POMC
restoration. RMA: genotype and genotype x time effects, p > 0.05. n = 5–6. In all graphs, error bars correspond to ±SEM.
After RMA, significant Genotype Effect was only taken into
account when Interaction (Genotype x Time) was not significant.
The total area under the curve (AUC) was calculated using the
trapezoidal rule.
RESULTS
With the aim of studying the role of POMC in glucose
homeostasis, we used an arcuate specific Pomc knockout
mouse model (arcPomc−/−) (2). These mice bare a floxed
neomycine-resistance gene (Neo) immediately downstream of
the hypothalamic Pomc neuronal enhancer module (Figure 1A).
Neo cassette prevents arcuate Pomc expression while preserving
transcription in the nucleus of the solitary tract and the pituitary
gland, avoiding corticosterone insufficiency (2).
Arcuate Pomc deficiency leads to obesity the fifth week
after birth, which predisposes to Type 2 Diabetes in adult
mice (2). Thus, in order to dissect the role of POMC
in the regulation of glucose homeostasis independently of
obesity mechanisms, we performed GTTs in arcPomc−/− mice
immediately after weaning, while animals still have normal
body weights. Interestingly, we found that despite no significant
differences in basal glycemia, female arcPomc−/− are less tolerant
to a glucose overload thanWT littermates [RMA, genotype effect:
F(1,9) = 5.992, p= 0.0369, n= 5–6 per group].
To further confirm that hypothalamic POMC prevents
glucose intolerance, we restored eutopic POMC expression by
crossing arcPomc−/− mice with a tamoxifen inducible Cre
mouse line (Figure 1A). We have previously shown that POMC
recovery at P25 completely prevents hyperphagia and obesity
in arcPomc−/−:Cre mice (2). Like arcPomc−/−, arcPomc−/−:Cre
female mice showed decreased glucose tolerance despite
normal body weight (Figure 1D). However, glucose tolerance
is completely normalized in arcPomc−/−:Cre after POMC
restoration, which further suggests a protective role of POMC
against diabetes (Figures 1E,F).
In order to address if glucose tolerance impairment triggered
by POMC deficiency is caused by decreased insulin sensitivity,
another cohort of arcPomc−/−:Cre and Cre female mice were
subjected to an ITT. Interestingly, non-obese arcPomc−/−:Cre
females show decreased insulin sensitivity that was normalized
by POMC restoration (Figures 1G,H). Glucose intolerance and
insulin resistance of arcPomc−/−:Cre females before POMC
restoration are not caused by increased inguinal, retroperitoneal
or liver fat stores, nor food intake, because no significant
differences were found when compared to Cre control mice
(Figures 1I–L). Altogether, these results suggest that POMC
prevents glucose intolerance by improving insulin sensitivity
through mechanisms not related to energy balance regulation or
fat storage.
Although it has been previously shown that hypothalamic α-
MSH enhances insulin inhibition of hepatic gluconeogenesis in
rats (22), we found no significant differences in PTTs between
female arcPomc−/−:Cre and Cre littermates (Figures 1M).
Contrary to females, non-obese POMC deficient male mice
showed normal glucose tolerance and insulin sensitivity, while
exhibiting normal food intake, inguinal and retroperitoneal
adiposity, liver weights and pyruvate tolerance (Figures 1N–T).
To further characterize if POMC neurons also show sexual
dimorphism in terms of response to glucose overload, we
measured C-FOS immunoreactivity in POMC neurons of
POMC-EGFP mice injected either with glucose or saline
(Figure 2A). Surprisingly, glucose elicited greater C-FOS
expression in arcuate POMC neurons of females than males
(Figure 2B). Notably, while C-FOS expression in POMC
neurons of glucose treated females was 71.8 ± 5.5% higher
than that of saline treated controls, males showed a difference
of only 29.5 ± 5.7% (t-test: p < 0.01). Since a subpopulation
of POMC neurons express estrogen receptor alpha (ESR1),
which was postulated to control glucose homeostasis (23), we
studied C-FOS induction by glucose overload specifically in
POMC-ESR1 neurons (Figure 2C). Interestingly, we found that,
despite the percentage of POMC neurons expressing ESR1 is
similar in males and females (38.9 ± 1.5% and 42.8 ± 1.7%,
respectively), glucose significantly increased C-FOS expression
only in POMC-ESR1 neurons of female mice (Figure 2D).
DISCUSSION
In the present work, we studied the regulation of glucose
homeostasis by using a reversible POMC knockout mouse
model with a unique feature, in which glucose homeostasis
and insulin sensitivity can be tested before and after POMC
restoration, providing strong evidence for an association between
hypothalamic POMC expression and regulation of glucose
homeostasis. Our results show that POMC deficiency impairs
insulin sensitivity and glucose tolerance in non-obese juvenile
female mice. These findings are in line with previous studies
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FIGURE 2 | Induction of C-FOS expression by peripheral glucose overload in POMC neurons. (A) Representative coronal brain sections of POMC-EGFP female mice
injected at P22-25 with saline (top) or glucose (bottom), subjected to anti-C-FOS immunofluorescence. Right panels show magnified images of squared areas
depicted in left panels. Green: EGFP expression of POMC neurons. Red: C-FOS immunopositive neurons. Arrows indicate examples of POMC neurons positive for
C-FOS. (B) Percentage of POMC neurons expressing C-FOS in male and female mice treated either with saline or glucose. POMC neurons per hemi-section: 58.45 ±
10.7; sections per animal: 7 ± 1.7 (mean ± SD). n = 4–5. (C) Representative coronal brain section of POMC-EGFP female mice injected at P22-25 with glucose (top),
subjected to double C-FOS and ERS1 immunofluorescence. Bottom panels show magnified images of squared area depicted in top panel. Green: EGFP expression
of POMC neurons. Red: C-FOS immunopositive neurons. Blue: ERS1 immunopositive neurons. Arrows: POMC/C-FOS/ESR1 neuron; *: POMC/C-FOS. Arrowhead:
POMC/ESR1 neuron. (D) Percentage of POMC/ESR1 neurons expressing C-FOS in male and female mice treated either with saline or glucose. POMC neurons per
hemi-section: 50.6 ± 14.1; sections per animal: 6.1 ± 0.9 (mean ± SD). n = −3–4. Error bars correspond to ±SEM. #p < 0.05 and ##p < 0.01 (TWA, sex x
treatment effect); *p < 0.05, **p < 0.01, and ***p < 0.001 (Bonferroni).
showing that the disruption of glucose signaling in POMC
neurons impairs glucose homeostasis (10, 12, 13). It was also
previously shown that POMC deficiency leads to decrease
insulin sensitivity in obese and food restricted mice, both
with elevated body fat composition (24). In addition, here
we found that POMC deficiency leads to insulin resistance
and glucose intolerance before the onset of obesity in ad
libitum-fed female mice characterized by normal food intake,
body weight and inguinal, retroperitoneal and liver fat stors.
Therefore, the protective role of POMC in glucose homeostasis
is presumably achieved by mechanisms independent of those
involved in energy balance control. One of the major findings
of our study is that POMC recovery completely restores
insulin sensitivity and glucose tolerance, which emphasizes the
importance of POMC in the regulation of glucose homeostasis.
This regulation may be mediated by α-MSH since it was shown
that insulin sensitivity is impaired in α-MSH receptor knockout
mice through mechanisms involving the sympathetic neural
system (25, 26). Regardless the pathway involved, since pyruvate
tolerance was unaltered in our model of POMC deficiency,
impaired glucose uptake rather than liver glucose production
might be responsible for insulin intolerance.
Sexual dimorphism is an interesting feature of POMCneurons
concerning the regulation of glucose homeostasis. Here, we
found that POMC deletion in hypothalamic neurons leads
to glucose intolerance and insulin resistance only in females.
Furthermore, glucose-elicited POMC neuron activity is greater
in female than in males and the subpopulation of POMC-ESR1
neurons response to glucose only in female mice. However,
since glucose was injected systemically, our experiments do
not distinguish between a direct or indirect action of glucose
in POMC neurons. In either case, we speculate that sexual
dimorphism found in our study is a consequence of estradiol
(E2) facilitation of POMC activity since it was previously shown
that estradiol prevents insulin resistance in POMC neurons of
diet induced obese female but not male mice (27). Furthermore,
it was demonstrated that E2 increases excitatory inputs, C-
FOS protein and Pomc mRNA expression in POMC neurons
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of wild-type females (28, 29). Interestingly, female mice lacking
estrogen receptor alpha only in POMC neurons develop insulin
resistance and glucose intolerance (23). We hypothesize the
existence of a protective pathway linking glucose signaling,
ESR1, hypothalamic POMC and glucose homeostasis which is
specific to females. Remarkably, women have lower prevalence
of diabetes than men despite having higher prevalence of obesity
(30). On this regard, our results shed light on the mechanisms
underlying gender differences in diabetes pathophysiology.
In summary, we show for the first time a protective role
of hypothalamic POMC peptide against glucose intolerance by
mechanisms that are independent of POMC role in energy
balance. Finally, since Pomc reactivation completely reverses the
diabetogenic phenotype, arcuate POMC might be a potential
target for diabetes therapy, particularly type 2 diabetes.
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